KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Enterprise Value (2016 - 2025)

Quest Diagnostics' Enterprise Value history spans 17 years, with the latest figure at -$384.0 million for Q4 2025.

  • For Q4 2025, Enterprise Value rose 17.6% year-over-year to -$384.0 million; the TTM value through Dec 2025 reached -$384.0 million, up 17.6%, while the annual FY2025 figure was -$384.0 million, 17.6% up from the prior year.
  • Enterprise Value for Q4 2025 was -$384.0 million at Quest Diagnostics, down from -$351.0 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$67.0 million in Q3 2023 and bottomed at -$1.2 billion in Q1 2021.
  • The 5-year median for Enterprise Value is -$451.5 million (2024), against an average of -$479.2 million.
  • The largest annual shift saw Enterprise Value soared 89.89% in 2023 before it tumbled 920.9% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$793.0 million in 2021, then soared by 64.94% to -$278.0 million in 2022, then crashed by 119.42% to -$610.0 million in 2023, then increased by 23.61% to -$466.0 million in 2024, then grew by 17.6% to -$384.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Enterprise Value are -$384.0 million (Q4 2025), -$351.0 million (Q3 2025), and -$282.0 million (Q2 2025).